TickerFactsScreenerDevelopers

Spyre Therapeutics, Inc. (SYRE) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2014: $181.0K2015: $208.0K2016: $212.0K2017: $619.0K2018: $422.0K2019: $1.49M2020: $4.28M2021: $573.0K2022: $38.0K2023: $02024: $0$0
2014Capital Expenditures (USD)2024
Fiscal YearCapital ExpendituresChange YoY
2024$0—
2023$0-100.0%
2022$38.0K-93.4%
2021$573.0K-86.6%
2020$4.28M+186.9%
2019$1.49M+253.6%
2018$422.0K-31.8%
2017$619.0K+192.0%
2016$212.0K+1.9%
2015$208.0K+14.9%
2014$181.0K—